HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Author Information
Author(s): Satou Yorifumi, Yasunaga Jun-ichirou, Zhao Tiejun, Yoshida Mika, Miyazato Paola, Takai Ken, Shimizu Kei, Ohshima Koichi, Green Patrick L., Ohkura Naganari, Yamaguchi Tomoyuki, Ono Masahiro, Sakaguchi Shimon, Matsuoka Masao
Primary Institution: Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan
Hypothesis
Transgenic expression of HBZ in CD4+ T cells induces T-cell lymphomas and systemic inflammation.
Conclusion
The study shows that HBZ expression in CD4+ T cells is a key mechanism of HTLV-1-induced neoplastic and inflammatory diseases.
Supporting Evidence
- HBZ transgenic mice developed skin lesions and T-cell lymphomas.
- Transgenic expression of HBZ increased Foxp3+ Treg cells but impaired their function.
- HBZ interacts with Foxp3 and NFAT, disrupting Treg cell function.
Takeaway
This study found that a virus can make certain immune cells grow too much and not work properly, which can lead to cancer and inflammation.
Methodology
Transgenic mice expressing the HBZ gene were analyzed for T-cell proliferation and lymphoma development.
Limitations
The study primarily uses a mouse model, which may not fully replicate human disease.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website